These new articles for Journal of Asthma are available online
New for Journal of Asthma and online now on Taylor & Francis Online: Articles Detecting asthma exacerbations using daily home monitoring and machine learningOlivier Zhang, Leandro L. Minku & Sherif GonemPages: 1-11 | DOI: 10.1080/02770903.2020.1802746 Factors associated with electronic cigarette use among adolescents asthma in the republic of koreaChang Hoon Han & Jae Ho ChungPages: 1-14 | DOI: 10.1080/02770903.2020.1802745 […]
Journal of Asthma, Volume 57, Issue 8, August 2020 is now available online on Taylor & Francis Online
This new issue contains the following articles:Epidemiology Trends and predictors of hospitalization after emergency department asthma visits among U.S. Adults, 2006–2014Michelle P. Lin MD, MPH, MS, Carmen Vargas-Torres MA, Jeremiah D. Schuur MD, MHS, Dorothy Shi MD, Juan Wisnivesky MD, DrPH & Lynne D. Richardson MDPages: 811-819 | DOI: 10.1080/02770903.2019.1621889Underserved Populations Creating a community-based comprehensive intervention to […]
Inhaled corticosteroid beliefs, complementary and alternative medicine in children presenting to the emergency department for asthma
Bahareh Ravandi , MD,Maureen George , PhD,Lindsey Thompson,Sitaram Vangal Vangala,Todd Chang &Sande Okelo https://doi.org/10.1080/02770903.2020.1786113 ABSTRACT Objective: Negative beliefs about inhaled corticosteroids (ICS) and endorsement of complementary and alternative medicine (CAM) have been associated with medication non-adherence and uncontrolled asthma. The association of CAM and negative health beliefs is not described in children in acute care settings. Our study […]
Usability of mepolizumab single-use prefilled syringe for patient self-administration
Journal of Asthma Volume 57, 2020 – Issue 7 Elisabeth H. Bel , MD, PhD,David I. Bernstein , MD,Leif Bjermer , MD, PhD,Richard Follows , BSc,Jane H. Bentley , MSc,Isabelle Pouliquen , PharmD & show all Abstract Objective: A liquid mepolizumab formulation in a single-use prefilled syringe (PFS) is under development. We evaluated the usability of mepolizumab self-injected via PFS by patients with severe eosinophilic […]
Differences in diagnostic patterns of obstructive airway disease between areas and sex in Sweden and Finland – the Nordic EpiLung study
Malin Axelsson , RN, PhD,Pinja Ilmarinen , PhD,Helena Backman , PhD,Linda Ekerljung , PhD,Linnea Hedman , PhD,Arnulf Langhammer , MD, PhD, show all Download citation https://doi.org/10.1080/02770903.2020.1776727 Abstract Objective: To investigate the current prevalence of physician-diagnosed obstructive airway diseases by respiratory symptoms and by sex in Sweden and Finland. Method: In 2016, a postal questionnaire was answered by 34,072 randomly selected adults in four study […]
Journal of Asthma, Volume 57, Issue 7, July 2020 is now available online
This new issue contains the following articles:Epidemiology Asthma prevalence among women aged 18 to 44 in the United States: National health and nutrition examination survey 2001–2016Katrina F. Flores MPH, Gretchen Bandoli PhD, Christina D. Chambers PhD, MPH, Michael Schatz MD, MS & Kristin Palmsten ScDPages: 693-702 | DOI: 10.1080/02770903.2019.1602874Prevalence of asthma and respiratory symptoms during pregnancy […]
Usability of mepolizumab single-use prefilled syringe for patient self-administration
Elisabeth H. Bel , MD, PhD,David I. Bernstein , MD,Leif Bjermer , MD, PhD,Richard Follows , BSc,Jane H. Bentley , MSc,Isabelle Pouliquen , PharmD & show all Abstract Objective: A liquid mepolizumab formulation in a single-use prefilled syringe (PFS) is under development. We evaluated the usability of mepolizumab self-injected via PFS by patients with severe eosinophilic asthma (SEA), or their caregivers, in clinic and […]
Position Statement: Asthma in Latin America. Is Short-Acting Beta-2 Agonist Helping or Compromising Asthma Management?
LJ Nannini,S Luhning,RA Rojas,JM Antunez,JL Miguel Reyes,Salas C Cano & show all In Latin-America, with 603 million inhabitants, the average prevalence of asthma is estimated at 17%, but with wide fluctuations, ranging from 5% in some cities (Mexico) to 30% in Costa Rica. The risk of severe exacerbations seems to be higher in Latin America compared with […]
Identifying the drivers of patients’ reliance on short-acting β2-agonists in asthma
Journal of Asthma, DOI: 10.1080/02770903.2020.1761382 Sarah Blakeston , MA,Gavin Harper , BA &Julen Zabala Mancebo , BEng, MSc, PhD Abstract Background: One of the most commonly observed asthma treatment patterns is the underuse of inhaled corticosteroid (ICS) maintenance therapy when patients are not experiencing symptoms, and the predominant use of short-acting β2-agonists (SABAs) when patients are experiencing symptoms. This multinational study investigated […]
Important updates on World Asthma Day 2020
On this year’s World Asthma Day, various research organizations, medical societies and patient advocacy groups are seeking to raise awareness about this common respiratory disease and the current research into its prevention and treatment, especially in the midst of the COVID-19 pandemic. In a press release, the NIH noted that COVID-19, which can affect the […]